Arra, A., D. . Coso, and L. . Chagas Guimaraes. “SATB.2 Is a Sensityive for Well Differentiated Neuroendocrine Tumors”. Interamerican Journal of Health Sciences, no. 1, Dec. 2021, doi:10.59471/ijhsc20214.